Present Your Research at RDD Europe 2025

The Poster Session at RDD Europe 2025 presents research on all aspects of pulmonary and nasal delivery. The abstract submission deadline was January 24, 2025 and the submission portal is now closed. Posters will be presented in Lisbon as a traditional poster augmented by a ten-minute recorded presentation for on-demand viewing.

Accepted abstracts will be published in the Conference Proceedings available to all conference delegates, and those from graduate students will be automatically eligible for the VCU RDD Peter R. Byron Graduate Student Award. The award covers registration fee, travel expenses and accommodation up to a maximum of $2000.

Posters on the Podium will showcase editor-selected posters during a series of ten-minute live presentations in the main auditorium followed by a fast-paced Q&A session. All poster abstracts and on-demand presentations will be featured in online Knowledge Spaces.

Registration fees will be waived for up to 20 graduate students (no more than 2 per advisor) with an accepted poster abstract if their academic advisor is registered to attend at the discounted academic rate of €995. It is expected that the graduate student (not their academic or industrial advisor) will present the poster in Lisbon. By waiving the registration fee, we hope to encourage young scientists to attend RDD, where they'll receive expert feedback on their work, hear the latest from opinion leaders, and network with peers, collaborators and future employers.

When and Where?

Posters will be continuously accessible to in-person delegates from 9:30 AM to 6:00 PM on Wednesday, May 7, 8:30 AM to 6:00 PM on Thursday, May 8, and 8:30 AM to 12:30 PM on Friday, May 9. The Poster and Exhibition Session will be the only RDD event during the following times:

Posters, exhibit tables, meals and refreshment breaks will share an expansive space to maximize interactivity.

Poster Abstract Writing Guidelines and Submission Instructions

We strive to publish impactful, scientifically accurate high-quality abstracts. Those with a high chance of acceptance:

  • Describe recent, relevant experiments, innovations and insights
  • Include data or outline groundbreaking concepts or approaches
  • Support claims and conclusions with data or references, especially those making comparisons to competing commercial products
  • Use scientific language understandable by researchers in the field
  • Have not been presented at other conferences

Three- to five-page poster abstracts should be submitted in Microsoft Word. Use double-spaced Arial 12-point font. Please follow instructions in the Poster Abstract Guidelines and share these with any colleagues or third-party vendors who are assisting you.

Poster Abstract Guidelines

The Publication Process

  • You must submit your poster abstract using the web portal before January 24, 2025.
  • A reviewer will evaluate your submitted poster abstract and communicate a decision to the primary author before March 7, 2025. Reviewers may accept, reject or request modifications. Corrections must be made within 5 days.
  • You must obtain and send us permission from the original publisher to include previously published materials in your poster abstract. Permission should be sent to info@rddonline.com. Most publishers have their own process to request permission but if not, please use our Copyright Permission Request Form.
  • Your reviewer will accept or reject your final abstract before March 31, 2025.
  • You must email a signed Copyright Transfer Form (as a PDF) to info@rddonline.com by March 31, 2025 so we can publish your work. Authors retain the right to use the content of their articles as they see fit, including extending their work into manuscripts submitted to journals. The Copyright Transfer Form gives RDD ownership of the final typeset abstract. We grant complimentary permission to use tables, figures and verbatim quotations in journal articles in exchange for acknowledgement that RDD was the original publisher.
  • The publisher will typeset your abstract and email you PDF proofs to review and correct. You should return the proofs by email within 48 hours of receipt. Please only make typographical corrections at this stage.
  • Questions about the publication process should be sent to Richard Dalby, University of Maryland.

On-Demand Narrated Presentations Guidelines - Deadline April 11, 2025

All conference participants want to see your research but may not have time to view all posters in Estoril. We therefore ask presenters to create a compelling 10-minute narrated slide presentation that gives delegates a good appreciation of your work wherever they are. The RDD audience is familiar with many aspects of nasal and pulmonary delivery so keep the background short. Focus on clearly presenting data and conclusions in your abstract. Ensure all claims, especially those that mention competitors, are supported by data or references. Do not include wildly speculative or unsubstantiated comments.

Approximately 8 slides should first be prepared using PowerPoint before using the recording function to add your voice-over narration. Presentations that exceed 10 minutes may end abruptly once posted on our platform. Practice your timing before making your final recording.

Slide Preparation

Step 1. Make slides in 16 x 9 format.

  • Slide 1: Presentation title (exactly the same as your poster abstract), names of all presenters and their institution(s). Optionally, include contact information and the presenter's photo. Please note that you are consenting to this information being visible to delegates on all RDD websites when you send us your slides. 
  • Slide 2: Background/Introduction
  • Additional 1 or 2 Slides: Outline your methods, technology or service
  • Additional 3 or 4 Slides: Describe your data and insights and highlight their significance
  • Avoid complex backgrounds, logos or slide designs which take up too much room and detract from the information you are presenting. Some delegates may watch your presentation on a small screen.
    • Use plain fonts such as Arial and ensure text is legible on a tablet or monitor. Use the largest font possible for maximum visibility (no smaller than 18 point is recommended).
    • Ensure the axes on graphs are clearly labelled. Thicken lines and use highly visible colors and/or symbols to differentiate among data sets. Provide a key. Do not include graphic elements you will not discuss.
    • Figures and photographs should be clearly visible. 
    • Avoid ‘busy’ slides packed with text or numbers. Instead stick to a few key points.

Step 2. Add your voice-over narration. This How-To-Video supplements the summary below. Please practice your timing before recording your presentation. 

  • Prepare to record in a quiet location.
  • Open the presentation and click the Slide Show tab.
  • Check your microphone is set up correctly. A headset generally produces the best quality audio.
  • Select the slide where you want the recording to begin then click Record Slide Show and start talking.
  • Click End Show to stop recording.
  • A Save dialog box appears. Click Yes to save your recording, or No, if you want to record it again. Saving overwrites anything you've previously recorded. It is possible to re-record individual slides.
  • Click Play from Start to preview or review your recording.

Step 3. Submit your file.
Send your final PowerPoint (.pptx) file to info@rddonline.com before April 11, 2025.

Send your final PowerPoint (.pptx) file

If the file is too large to e-mail, your organization may have a preferred file transfer protocol (FTP), but if not, we recommend using wetransfer.com.

Preparing and Displaying a Poster

Posters give you the opportunity to display innovative research and technology and interact face-to-face with conference delegates. You are also strongly encouraged to prepare an on-demand recorded presentation in order to share your work with all delegates. These will be posted in the appropriate Knowledge Space through June 30 (see On-Demand Narrated Presentation Guidelines). Taking this extra step allows all delegates to ask you questions using Messaging and means you are ready if invited to participate in Posters on the Podium. 

Poster Boards

  • We will assign a display location with the dimensions shown in the diagram:
    • Maximum Poster Height: 118 cm (1.18 meters)
    • Maximum Poster Width: 136 cm (1.36 meters)
  • Your poster can be attached to the board with adhesive pads, which we will supply at the conference.
  • There will not be a table below the poster board.
  • Posters do not have access to electricity.

Making an Impact

Posters provoke the most discussion when you follow three simple rules:

  • Make the text large and legible. We recommend a dark-colored font, readable at six feet.
  • Focus on one or two essential themes and emphasize novel findings.
  • Keep the overall design simple, but include legible diagrams, tables, and figures.

If you need to ship your poster rather than hand-carry, see Shipping Instructions posted on our website.
 

Poster Session Etiquette

Poster content must be closely related to your published abstract. All claims and conclusions must be supported by data or references. Do not include speculative or unsubstantiated comments.

The major attraction of a poster is you, the presenter. Please be present at your poster to answer questions for at least an hour each time the Poster Session is open. If you don’t plan to stay at your poster the whole time, it’s helpful to display a sign showing the times you plan to be present.

Poster Set-up and Take-down

  • Set-up is encouraged on Tuesday, May 6, between 3:00 PM–6:00 PM. Please visit the Registration Desk, review the conference program for the floor plan to find your assigned poster location. Do not set up in a different location. Late arrivals may set up on Wednesday, May 7, from 7:30 to 8:30 AM.
  • We recommend that you take small, high-value items such as laptops and prototype devices with you when you are not at your poster or when leaving the space for the evening.
  • A Poster and Exhibition Floor Plan will be provided to all delegates.
  • Posters must be removed by 2:00 PM on Friday, May 9.

The meeting organizers and the Estoril Congress Center expressly disclaim responsibility for loss or damage to any items you bring into the Poster and Exhibition space.

Poster Presentations

Aptar Digital Health
Akash Bijlani
Impact of the Aptar Digital Health Respiratory Disease Management Platform on Adult Asthma: Part of the REGAIN (Real World and Genomic Data Based Asthma Insight Through Network Analysis) Study
Abstract Received and In Review
Goncalo Farias
Comprehensive Analysis of Variables Affecting Nasal Spray Product Actuation Force
Abstract Received and In Review
Karl Bass
Mapping the Product Design Space: Understanding and Controlling Manufacturing Variability in Pressurised Metered Dose Inhalers
Received by Publisher
Lei Mao and Ross Errington
Development of Albuterol Sulfate pMDI using a Low Global Warming Potential Propellant 1,3,3,3-Tetrafluoropropene (HFO1234ze) to Match Ventolin® HFA Inhaler: I. Formulation, Container Clo
Abstract Received and In Review
Lei Mao and Ross Errington
Development of Albuterol Sulfate pMDI Using a Low Global Warming Potential Propellant 1,3,3,3-tetrafluoropropene (HFO-1234ze) to Match Ventolin® HFA Inhaler: II. Inhaler Ha
In Publication
Cambridge Healthcare Innovations
Heather Jameson
High Delivered Dose in a Single Inhalation for Carrier-Based Formulations by Retaining Carrier-Fraction in DPI Blister
In Publication
MV
Michael Vernizzi
Formulation Study on siRNA-LNP Embedded in an Inhalable Freeze-Dried Matrix for Lung Targeting
Returned for Proof Reading
Chiesi Limited
Cristina Rey Blanes
Further Exploration on the Manufacturing Repeatability and the Interaction Between Blending Parameters of Dry Powder Blends Produced by Resonant Acoustic Mixing
Received by Publisher
RB
Ross Blezard

Impact of Lactose Carrier Morphology and Amorphicity on the Aerosol Performance  of Fluticasone Propionate DPIs

Accepted for Publication
RB
Federation University
Rob Bischof
Poly (ADP-Ribose) Polymerase Inhibition as a Treatment Option for Pulmonary Fibrosis
Abstract Received and In Review
Navid Monshi Tousi
Impact of Anatomical Variability on Nasal Deposition in Pediatric Subjects of the Same Age and Gender
Abstract Received and In Review
Hosein Sadafi
From Healthy to Diseased: Evaluating Bioequivalence in Orally Inhaled Drug Delivery
Abstract Received and In Review
Hosein Sadafi
Sensitivity Analysis of Inhaled Drug Deposition Delivered via Metered Dose Inhalers in COPD Patients
Abstract Received and In Review
Ameet Sule
Investigation of In Vitro Techniques for Evaluating Ipratropium Bromide Formulations
Received by Publisher
Gregory Smith
Performance Comparison of Beclomethasone, Formoterol, and Glycopyrronium Solution Formulations in HFO-1234ze(e) to Reference Listed Drugs
Received by Publisher
RC
Rui Churro
Advancing High-dosage DPI Formulations: Integrating Quality By Design For Optimized Performance
Abstract Received and In Review
Claudia Costa
Characterization Study of Nasal Deposition Targeting the Central Nervous System
Abstract Received and In Review
Alexandre Ribeiro
Distinct Baseline Phenotypical and Functional Properties of Macrophages Derived from Two Different Lots of THP-1 Monocytes for Screening the Effects of Inhalable Drugs
Abstract Received and In Review
Mark Parry
Aerosolization of Wegovy® and Prototype Formulations of Semaglutide with an SMI
Abstract Received and In Review
Anna Vivani
Preliminary Development of a Nanostructured Nasal Powder for Nose-to-Brain Delivery of a Neuro-Active Steroid
In Publication
LZ
Johns Hopkins University
Lily Zhu
Design, Development, and Validation of a Novel Dry Powder Inhaler Adaptor for Increased Deposition of Anti-Inflammatory Agents in Pediatric Asthma
Returned for Proof Reading
MW
Kiel University
Melvin Wostry
Optimization of Carrier Particle Geometry for Enhanced Inhalation Performance: Insights from In-Silico Studies and Experimental 3D Printed Carrier Particles
Abstract Received and In Review
Oliver Ingham
An Evaluation of Extractable Levels from Various Polybutylene Terephthalate (PBT) Supplies in the Presence of Ethanol in Formulations Containing HFA152a and HFO1234ze
Abstract Received and In Review
Aaron Taylor
Understanding Drug Deposition in USP and OPCM Throats for HFA-152a Solution pMDIs
In Publication
Lakehead University
Mahsa Jahed
Effects of Airway Wall Dynamics During Inhalation on Drug Delivery via pMDIs Using Patient-Specific Airway Models
In Publication
Lakehead University
Mona Mohammadkhani
Enhancing the Efficiency of pMDIs Through an Innovative Mesh Grid Design
In Publication
Camille Dumont
Selection of the Best Capsule Type to Maximize the Performance of a Model Carrier-Based Dry Powder Inhalation Formulation
Returned for Proof Reading
Cameron Kadleck
Spray Dried Lipid Nanoparticles for Intranasal Delivery
Received by Publisher
Beatriz Noriega Fernandes
Fine-Tuning Spray-Dried Inhalable Powders: Impact of Component Saturation on Performance
In Publication
Ludwig-Maximilians-University Munich
Leonie Deßloch
Inhalable Spray Dried Lipid Nanoparticles for Pulmonary siRNA Delivery
In Publication
Lund University
Kyrre Thalberg
The Role of Carrier Particle Size in Adhesive Mixtures for Inhalation
In Publication
Vaishnavi Kapileshwari and Mridul Majumder
Predicting Blend Performance of a Dry Powder Inhalation Formulation Using Raman Spectroscopy
Received by Publisher
Macquarie University
Chun Yuen Jerry Wong
Optimizing Intranasal Delivery of Peptides for Targeted Brain Drug Delivery in Transgenic Mouse Models of Alzheimer’s Disease
Abstract Received and In Review
Monash University
Tuncay Alan
Ultrasonically Actuated Platform for Delivering High-Viscosity Solutions with Adjustable Flow Rates
Abstract Received and In Review
MP
Monash University
Michael Pangestu
Experimental Investigation of the Fluid and Droplet Dynamics of a Soft Mist Inhaler
Abstract Received and In Review
Lucas Silva
The Impact of Orbital Device Puck Configurations on Itraconazole Deposition for the Treatment of Chronic Pulmonary Aspergillosis (CPA)
Returned for Revision
Lucas Silva
The Impact of Permeation Enhancers on Improving the Permeability of Spray-Dried Leuprolide Formulations Using RPMI-2650 Cells
Returned for Revision
Nebu~Flow
Sarina Saeidi
Sized Aerosol Sampling to Characterize Nebulized Biologics
Returned for Revision
Nebu~Flow
Kiing Seng Wong
An Acoustic Nebulizer Platform for Aerosolization of Biologics
In Publication
Steve Flaherty
An Assessment of the Potential Manufacturing Scale Flammability of Low GWP Formulations
Abstract Received and In Review
James Murray
Assessment of the Suspension Characteristics of Budesonide Micronised by Traditional Jet-Milling and by Sonocrystallisation Suspended in High and Low Global Warming Propellants
Abstract Received and In Review
Orexo AB
Jonas Sävmarker
Novel Spray Dried Nasal Powder of Eletriptan: In Vitro and Pre-Clinical In Vivo Studies
Returned for Revision
David Lewis
Plume Temperature: HFA 134a & HFA 227ea Compared to Low GWP Propellants HFA152a and HFO 1234ze
Returned for Revision
Andrea Winzen
Correlation of Leakage and Aerosol Performance Measurement for Five Valved Holding Chambers with Pediatric Facemasks
Returned for Revision
SH
Summer Hancock
The Importance of Shear Thinning for High Viscosity Nasal Suspensions
Abstract Received and In Review
IR
Iain Ross
Advancing Cleaning and Disinfection Standards for Mesh Nebulizers: A Patient-Centric Study Introducing Zerowater®
In Publication
Philip Smith
Simplified Mechanism Modelling: Optimizing a DPI for Ease of Use
In Publication
Politecnico di Torino
Lorena Pasero
Spray Freeze-Drying Inhalable Powders of a Monoclonal Antibody: The Role of Formulation in Achieving Stability and Flowability
In Publication
Politecnico di Torino
Lorena Pasero
The Influence of Freezing, Storage, and Formulation on Mannitol Polymorphism and Powder Deposition after Spray Freeze-Drying
In Publication
RM
Rohit Mulik
Low Bioburden Manufacturing of Nasal Spray Drug Products
Abstract Received and In Review
RIGImmune
Jag Shur
Modelling the Impact of Mucoadhesive Formulations on Intranasal Delivery of RIG-101, a Stem-Loop RNA Therapeutic
Abstract Received and In Review
RIGImmune
Jag Shur
Refining Regional Deposition Predictions in MDIs: A Comparison of Static and Dynamic ICRP Models
Accepted for Publication
Yannick Baschung
Evaluating Critical Handling Errors in Inhalation Devices: The Role of Tailored In-Vitro Testing
Abstract Received and In Review
Jamie Greenwood
Targeting ATMPS to the Lungs: It’s All in the Delivery
Returned for Revision
FR
Therakind Limited
Farsan Rahman
Development of a Particle Engineered Aspirin Powder for Intranasal Delivery: Evaluating Delivery Performance from a Novel Intranasal Device
Abstract Received and In Review
Jolyon Mitchell
Inhaled Maintenance and Reliever Therapy and Anti-Inflammatory-Reliever Therapy: Exploring In Vitro Performance of a Portable Valved Holding Chamber 
In Publication
Jason Suggett
Clinical Evaluation of a Prototype Smart Valved Holding Chamber (VHC) to Monitor and Improve Adherence to Metered Dose Inhaler (MDI) Medication
In Publication
University of Hertfordshire
Darragh Murnane
Pre-Actuation Microstructure Within DPI Blisters Revealed Through X-Ray Computed Tomography
In Publication
University of Hertfordshire
Lois Slator
Assessing Fitness-for-Purpose to Support Clinical Application of an Adaptive Breath-Actuated Nebulizer
In Publication
University of Hertfordshire
Giorgia Vaccaro
Development of a Single Actuation Impaction Method for Aerosolization Assessment of Soft Mist Inhalers: Comparison for MRX004 and Respimat®
In Publication
University of Leeds
Benjamin Mignot
Influence of Viscosity and Surface Tension on Droplet Size Distribution and Plume Characteristics of the Respimat Soft Mist Inhaler
In Publication
University of Limerick
Aoife Cotter
Development of a Dry Powder Formulation of Deoxyribonuclease I using Spray Drying 
In Publication
Stefania Glieca and Irene Rossi
Bulk Excipient Screening of a Spray Dried GLP-1 Receptor Agonist Formulation
Received by Publisher
Stefania Glieca
Lactobacilli Inhalation Powders as Antibacterial Agents Against S. Aureus
Received by Publisher
PD
University of Toronto
Peter Di Palma
A Comparison of Particle Dynamics Within Several Airway Models Using Phase Doppler Anemometry
Received by Publisher
Raneem Aldaqqa
Leveraging Chemo-Immunotherapy to Remodel the Tumor Microenvironment and Enhance Treatment Efficacy in Osteosarcoma Lung Metastases
In Publication
Rudra Pangeni
In Vivo Deposition and Retention of Ciprofloxacin Liposomal Dry Powder Aerosol
Accepted for Publication
Woolcock Institute of Medical Research
Patrick He
Evaluation of the Resyca® PFSI Soft Mist Inhaler for Efficient Delivery of mRNA-lipid Nanoparticles to the Lungs
Abstract Received and In Review
SE
World Medicine
Sulenur Ekmekci
Investigation of the Effect of Rheological Properties on Dissolution Character of Mometasone Furoate Nasal Spray Suspension
Abstract Received and In Review
GF
World Medicine
Gozde Fidan
Comparison of the Distributions of Droplets/Particles Smaller than 10 Microns of Nasal Spray Formulations Containing Fluticasone Propionate and Azelastine HCl Obtained from Laser Diffraction and NGI Methods
Abstract Received and In Review
RM
Ria Mitchell
3D Characterization of Pharmaceutical Powder Formulations and Medical Devices Using X-Ray Microscopy, Deep Learning, and AI
Returned for Revision

Questions?

For further information, contact Richard Dalby.

↑ Back to Top